1-4 of 4
Elizabeth Ahern
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT189: A first-in-human, phase 1a, dose-escalation study of BGB-10188, a phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor, + tislelizumab (anti-PD-1) in patients with solid tumors

Rasha Cosman, Elizabeth Ahern, Jie Li, Hui K. Gan, Yu Chen, Bo Gao, Yongsheng Wang, Xiyan Mu, Huan Cheng, Yanrong Qian, Heather Zhang, Ke Cao
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT189.
https://doi.org/10.1158/1538-7445.AM2024-CT189
Published: 05 April 2024
View articletitled, Abstract CT189: A first-in-human, phase 1a, dose-escalation study of BGB-10188, a phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor, + tislelizumab (anti-PD-1) in patients with solid tumors
Journal Articles

Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET

Eva Segelov, Amy Body, Stuart Turville, Corey Smith, Katie Lineburg, Sudha Rao, Robert McCuaig, Stephen Opat, Zin Niang, Luxi Lal, Vi Luong, Hesham Abdulla, Veronica Aedo Lopez, Bhavna Padhye, Noemi Fuentes Bolanos, Antoinette Anazodo, Raina MacIntyre, Peter Downie, Tracey O'Brien, Elizabeth Ahern
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT567.
https://doi.org/10.1158/1538-7445.AM2022-CT567
Published: 15 June 2022
View articletitled, Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET
Journal Articles

Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract

Eva Segelov, Amy Body, Vi Luong, Veronica Aedo Lopez, Luxi Lal, Hesham Abdulla, Stuart Turville, Zin Niang, Stephen Opat, Robert McCuaig, Katie Lineburg, Sudha Rao, Corey Smith, Raina MacIntyre, Elizabeth Ahern
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT259.
https://doi.org/10.1158/1538-7445.AM2022-CT259
Published: 15 June 2022
View articletitled, Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract
Journal Articles

Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis

Arabella Young, Shin Foong Ngiow, Jason Madore, Julia Reinhardt, Jennifer Landsberg, Arash Chitsazan, Jai Rautela, Tobias Bald, Deborah S. Barkauskas, Elizabeth Ahern, Nicholas D. Huntington, Dirk Schadendorf, Georgina V. Long, Glen M. Boyle, Michael Hölzel, Richard A. Scolyer, Mark J. Smyth
Journal: Cancer Research
Cancer Res (2017) 77 (17): 4684–4696.
https://doi.org/10.1158/0008-5472.CAN-17-0393
Published: 31 August 2017
View articletitled, Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis
Open the PDF for Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis in another window
Includes: Supplementary data